View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AB20 | Publication ID: Spring 2009 |
Title: ●Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 | |
Abstract: The Ryan Haight Online Pharmacy Consumer Protection Act, which was enacted on October 15, 2008, amended the Controlled Substances Act and Controlled Substances Import and Export Act by adding several new provisions to prevent the illegal distribution and dispensing of controlled substances by means of the Internet. DEA is hereby issuing an interim rule to amend its regulations to implement the legislation and is requesting comments on the interim rule. | |
Agency: Department of Justice(DOJ) | Priority: Other Significant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 1300 21 CFR 1301 21 CFR 1304 21 CFR 1306 | |
Legal Authority: PL 110-425 21 USC 802 21 USC 823 21 USC 827 21 USC 829 21 USC 831 ... |
Legal Deadline:
|
|||||||||||||||
Overall Description of Deadline: Regulatory authority of the Attorney General has been delegated to the Administrator of DEA. It is evident from the foregoing provision of the Act that Congress contemplated it would be necessary for DEA to issue regulations on an interim basis in order to implement the Act within the relatively short time period between the passage of the Act (October 15, 2008) and its effective date (April 13, 2009). |
|||||||||||||||
Timetable:
|
Additional Information: Please reference "Docket No. DEA-322" on all written and electronic correspondence. Written comments being sent via regular or express mail should be sent to the Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODL, 8701 Morrissette Drive, Springfield, VA 22152. Comments may be sent to DEA by sending an electronic message to dea.diversion.policy@usdoj.gov. | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Information URL: www.deadiversion.usdoj.gov | Public Comment URL: www.regulations.gov |
RIN Data Printed in the FR: No | |
Agency Contact: Mark W. Caverly Chief, Liaison and Policy Section Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:202 307-7297 Email: dea.diversion.policy@usdoj.gov |